Shaker Financial Services’s abrdn Life Sciences Investors HQL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$221K Sell
11,026
-63,191
-85% -$1.12M 0.07% 133
2026
Q1
$1.21M Sell
74,217
-41,202
-36% -$689K 0.42% 81
2025
Q4
$1.94M Sell
115,419
-82,385
-42% -$1.38M 0.61% 64
2025
Q3
$3.07M Buy
197,804
+166,742
+537% +$2.28M 1.05% 33
2025
Q2
$398K Buy
31,062
+7,632
+33% +$94.1K 0.14% 115
2025
Q1
$297K Buy
+23,430
New +$317K 0.12% 132
2024
Q1
Sell
-61,683
Closed -$840K 169
2023
Q4
$840K Sell
61,683
-4,845
-7% -$59.6K 0.34% 85
2023
Q3
$830K Buy
66,528
+1,342
+2% +$17.7K 0.39% 83
2023
Q2
$883K Sell
65,186
-1,342
-2% -$18.5K 0.39% 82
2023
Q1
$927K Buy
66,528
+1,500
+2% +$21.4K 0.41% 80
2022
Q4
$924K Buy
65,028
+3,161
+5% +$45.8K 0.43% 71
2022
Q3
$845K Buy
61,867
+5,000
+9% +$74.7K 0.42% 73
2022
Q2
$809K Buy
56,867
+40,583
+249% +$613K 0.39% 71
2022
Q1
$269K Buy
+16,284
New +$280K 0.1% 133
2021
Q3
Sell
-59,972
Closed -$1.29M 154
2021
Q2
$1.29M Buy
59,972
+40,441
+207% +$816K 0.48% 80
2021
Q1
$385K Buy
19,531
+835
+4% +$17.2K 0.15% 135
2020
Q4
$369K Hold
18,696
0.15% 132
2020
Q3
$329K Hold
18,696
0.18% 123
2020
Q2
$336K Buy
18,696
+2,660
+17% +$45.6K 0.19% 126
2020
Q1
$240K Buy
+16,036
New +$263K 0.16% 134
2014
Q1
Sell
-52,133
Closed -$1.07M 156
2013
Q4
$1.07M Buy
52,133
+29,012
+125% +$563K 0.74% 50
2013
Q3
$445K Buy
+23,121
New +$443K 0.33% 100

Other funds holding HQL

Shaker Financial Services's HQL Position: Q2 2026 in Review

Shaker Financial Services reduced its abrdn Life Sciences Investors (HQL) stake by 85% in Q2 2026, selling an estimated $1.12M and leaving 11,026 shares worth $221K. The position accounts for 0.07% of the portfolio, ranked #133.

Shaker Financial Services first reported a position in HQL in Q3 2013 and has held it in 22 quarters since. The position peaked at $3.07M in Q3 2025. 12 funds tracked by Wall St. Rank hold HQL as of Q2 2026.

  • Shaker Financial Services held 11,026 shares of abrdn Life Sciences Investors worth $221K as of Q2 2026.
  • Shaker Financial Services sold 63,191 abrdn Life Sciences Investors shares in Q2 2026, an estimated $1.12M.
  • abrdn Life Sciences Investors made up 0.07% of Shaker Financial Services's portfolio in Q2 2026, its #133 holding.
  • Shaker Financial Services first reported a position in abrdn Life Sciences Investors in Q3 2013 and has held it in 22 quarters since.
  • Shaker Financial Services's abrdn Life Sciences Investors position peaked at $3.07M in Q3 2025.
  • 12 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2026.

Based on Shaker Financial Services's 13F filing for Q2 2026, filed 15 Jul 2026.